Track and Trace: Draft Senate Bill Requires Unit-level System In 10 Years; House Opts For Study
This article was originally published in The Pink Sheet Daily
The difference in approach to unit-level tracing underscores the difficulty supporters of a national track-and-trace program face in gaining final approval of a bill before manufacturers go too far down the road in implementing a California pedigree law that goes into effect in 2015.
You may also be interested in...
Track-And-Trace Will Not Hitch A Ride On The User Fee Train
Efforts to reach a consensus proposal have been unsuccessful as the bill nears a possible final vote in the House.
Track And Trace: Substandard System Is Not Better Than Nothing, FDA Says
CDER Director Janet Woodcock says an industry coalition’s proposal would not meet FDA’s drug tracking needs and is not worth the cost of implementing, even though industry says FDA’s preference is cost-prohibitive.
Rx Misbranding Penalties Should Be Stronger To Stop Counterfeiting, FDA Says
Industry also seems supportive of the idea, while Pew touts the power of the power of track-and-trace as a deterrent.